Modulation of tumor cell response to chemotherapy by the organ environment (original) (raw)
References
Fidler IJ: Critical factors in the biology of human cancer metastasis: twenty-eight G.H.A. Clowes memorial award lecture. Cancer Res 50: 6130–6138, 1990 Google Scholar
Fidler IJ, Poste G: The cellular heterogeneity of malignant neoplasms: implications for adjuvant chemotherapy. Semin Oncol 12: 207–221, 1985 Google Scholar
Heppner G: Tumor heterogeneity. Cancer Res 44: 2259–2265, 1984 Google Scholar
Dexter DL, Leith JT: Tumor heterogeneity and drug resistance. J Clin Oncol 4: 244–257, 1986 Google Scholar
Fidler IJ, Balch CM: The biology of cancer metastasis and implications for therapy. Curr Probl Surg 24: 137–209, 1987 Google Scholar
Paget S: The distribution of secondary growths in cancer of the breast. Lancet 1: 571–573, 1889 Google Scholar
Fidler IJ, Kripke ML: Metastasis results from pre-existing variant cells within a malignant tumor. Science 197: 893–895, 1977 Google Scholar
Price JE, Aukerman SL, Fidler IJ: Evidence that the process of murine melanoma metastasis is sequential and selective and contains stochastic elements. Cancer Res 46: 5172–5178, 1986 Google Scholar
Talmadge JE, Wolman SR, Fidler IJ: Evidence for the clonal origin of spontaneous metastasis. Science 217: 361–363, 1982 Google Scholar
Fidler IJ, Talmadge JE: Evidence that intravenously derived murine pulmonary metastases can originate from the expansion of a single tumor cell. Cancer Res 46: 5167–5171, 1986 Google Scholar
Hart IR, Fidler IJ: Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res 41: 1281–1287, 1981 Google Scholar
Tsuruo T, Fidler IJ: Differences in drug sensitivity among tumor cells from parental tumors, selected variants, and spontaneous metastases. Cancer Res 41: 3058–3064, 1981 Google Scholar
Teicher BA, Herman TS, Holden SA, Wang Y, Pfeffer MR, Crawford JW, Frei E: Tumor resistance to alkylating agents conferred by mechanisms operative only_in vivo_. Science (Washington DC) 247: 1457–1461, 1990 Google Scholar
Schneiderman MA: The clinical excursion into 5-fluorouracil. Cancer Chemother Rep 16: 107–116, 1962 Google Scholar
Donelli MG, Rosso R, Garatini S: Selective chemotherapy in relation to the site of tumor transplantation. Int J Cancer 32: 78–86, 1975 Google Scholar
Donelli MG, Colombo T, Broggini M, Garattini S: Differential distribution of antitumor agents in primary and secondary tumors. Cancer Treat Rep 61: 1319–1324, 1977 Google Scholar
Slack NH, Bross JDJ: The influence of site of metastasis on tumor growth and response to chemotherapy. Br J Cancer 32: 78–86, 1975 Google Scholar
Teicher BA, Herman TS, Holden SA, Wang Y, Pfeffer MR, Crawford JW, Frei E: Tumor resistance to alkylating agents conferred by mechanisms operative only_in vivo_. Science (Washington DC) 247: 1457–1461, 1990 Google Scholar
Holst E, Sievers U, Schmahl D: Experimental investigations about the chemosensitivity of transplantation tumor at different sites of transplantation. Z Krebsforsch 76: 325–329, 1971 Google Scholar
Vaupel P, Kallinowski F, Okunieff P: Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449–6465, 1989 Google Scholar
Teicher BA, Lazo JS, Sartorelli AC: Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res 41: 73–81, 1981 Google Scholar
Sartorelli AC: Therapeutic attack of hypoxic cells of solid tumors: presidential address. Cancer Res 48: 775–778, 1988 Google Scholar
Moulder JE, Rockwell S: Tumor hypoxia: its impact on cancer therapy. Cancer Metastasis Rev 5: 313–341, 1987 Google Scholar
Tannock IF, Rotin D: Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 49: 4373–4384, 1989 Google Scholar
Boyer MJ, Barnard M, Hedley DW, Tannock IF: Regulation of intracellular pH in subpopulations of cells derived from spheroids and solid tumors. Br J Cancer 36: 890–897, 1993 Google Scholar
Volk T, Jahde E, Fortmeyer HP, Glusenkamp K-H, Rajewsky MF: pH in human tumour xenografts: effect of intravenous administration of glucose. Br J Cancer 68: 492–500, 1993 Google Scholar
Jain RK: Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J Natl Cancer Inst 81: 570–576, 1989 Google Scholar
Suzuki M, Hori K, Abe I: A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II. J Natl Cancer Inst 67: 663–669, 1981 Google Scholar
Tozer GM, Lewis S, Michalowski A, Aber V: The relationship between regional variations in blood flow and histology in a transplanted rat fibrosarcoma. Br J Cancer 61: 250–257, 1990 Google Scholar
Jain RK: Transport of molecules across tumor vasculature. Cancer Metastasis Rev 6: 559–593, 1987 Google Scholar
Suzuki M, Hori M, Abe I, Sachiko S, Sato H: Functional characterization of the microcirculation in tumors. Cancer Metastasis Rev 3: 115–126, 1984 Google Scholar
Fidler IJ: Macrophages and metastasis: a biological approach to cancer therapy. Cancer Res 45: 4714–4726, 1985 Google Scholar
Bradley G, Juranka PE, Ling V: Mechanism of multidrug resistance. Biochim Biophys Acta 948: 87–128, 1988 Google Scholar
Rothenberg M, Ling V: Multidrug resistance: molecular biology and clinical relevance. J Natl Cancer Inst 81: 907–910, 1989 Google Scholar
Pastan I, Gottesman MM, Ueda K, Lovelace E, Rutherford AV, Willingham MC: A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Acad Sci USA 85: 4486–4490, 1988 Google Scholar
Croop JM, Gros P, Housman DE: Genetics of multidrug resistance. J Clin Invest 81: 1303–1309, 1988 Google Scholar
Kanamaru H, Kakehi Y, Yoshida O, Nakanishi S, Pastan I, Gottesman MM: MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants. J Natl Cancer Inst 81: 844–849, 1989 Google Scholar
Kartner N, Riordan JR, Ling V: Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221: 1285–1288, 1983 Google Scholar
Chabner BA, Fogi A: Multidrug resistance: P-glycoprotein and its allies - the elusive foes. J Natl Cancer Inst 81: 910–913, 1989 Google Scholar
Koch G, Smith M, Twentyman P, Wright K: Identification of a novel calcium-binding protein (CP22) in multidrug-resistant murine and hamster cells. FEBS Lett 195: 275–279, 1986 Google Scholar
Hamada H, Okochi E, Oh-hara T, Tsuruo T: Purification of the Mr 22,000 calcium-binding protein (sorcin) associated with multidrug resistance and its detection with monoclonal antibodies. Cancer Res 48: 3173–3178, 1988 Google Scholar
Deffie AM, Alam T, Seneviratne C, Beenken SW, Batra JK, Shea TC, Henner WS, Goldenberg GJ: Multifactorial resistance to Adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of Adriamycin-sensitive and -resistant P388 leukemia. Cancer Res 48: 3595–3602, 1988 Google Scholar
Tsuruo T, Iida H, Kawabara H, Tsukagoshi S, Sakurai Y: High calcium content of pleiotropic drug-resistant P388 and K562 leukemia and Chinese hamster ovary cells. Cancer Res 44: 5095–5099, 1984 Google Scholar
Nair S, Samy TS, Krishan A: Calcium, calmodulin, and protein content of Adriamycin-resistant and -sensitive murine leukemia cells. Cancer Res 46: 229–232, 1986 Google Scholar
Baskin F, Rosenberg RN, Dev V: Correlation of doubleminute chromosomes with unstable multidrug cross-resistance in uptake mutants of neuroblastoma cells. Proc Natl Acad Sci USA 78: 3654–3658, 1981 Google Scholar
O'Brian CA, Ward NE: Biology of the protein kinase C family. Cancer Metastasis Rev 8: 199–214, 1989 Google Scholar
O'Brian CA, Fan D, Ward NE, Seid C, Fidler IJ: Level of protein kinase C activity correlates directly with resistance to Adriamycin in murine fibrosarcoma cells. FEBS Letts 246: 78–82, 1989 Google Scholar
Zwelling LA, Michaels S, Erickson LC, Ungeleier RS, Nichols M, Kohn K: Protein-associated DNA breaks in L1210 cells treated with the DNA intercalating agents 4'-(9-acridinylamino)-methanesulfon-_m_-anisidide and Adriamycin. Biochemistry 20: 6553–6563, 1981 Google Scholar
Glisson B, Gupta R, Hodges R, Ross W: Cross-resistance to intercalating agents in an epipodophyllotoxin-resistant Chinese hamster ovary cell line: evidence for a common intracellular target. Cancer Res 46: 1931–1941, 1986 Google Scholar
Tsuruo T: Mechanisms of multidrug resistance and implications for chemotherapy. Jpn J Cancer Res 79: 285–296, 1988 Google Scholar
Redmond SMS, Joncourt F, Buser K, Ziemiecki A, Altermatt H-J, Fey M, Margison G, Cerny T: Assessment of P-glycoprotein, glutathione-based detoxifying enzymes, and O6-alkylguanine-DNA alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumors. Cancer Res 51: 2092–2097, 1991 Google Scholar
Deuchars KL, Ling V: P-glycoprotein and multidrug-resistance in cancer chemotherapy. Semin Oncol 16: 156–165, 1989 Google Scholar
Staroselsky A, Fan D, O'Brian CA, Gupta KP, Fidler IJ: Site-dependent differences in response of the UV-2237 murine fibrosarcoma to systemic therapy with Adriamycin. Cancer Res 40: 7775–7780, 1990 Google Scholar
Houghton PJ, Tew KD, Taylor DM: Some studies of the distribution and effects of cyclophosphamide in normal and neoplastic tissue. Cancer Treat Rep 60: 459–464, 1976 Google Scholar
Kripke ML, Gruys E, Fidler IJ: Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin. Cancer Res 38: 2962–2967, 1978 Google Scholar
Radinsky R: Growth factors and their receptors in metastasis. Semin Cancer Biol 2: 169–177, 1991 Google Scholar
Rice GC, Ling V, Schimke RT: Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and doxorubicin (Adriamycin) resistance. Proc Natl Acad Sci USA 84: 9261–9264, 1987 Google Scholar
Roizin-Towle L, Hall EJ: Studies with bleomycin and misonidasole on aerated and hypoxic cells. Br J Cancer 37: 254–260, 1978 Google Scholar
Smith E, Stratford IJ, Adam GE: Cytotoxicity of Adriamycin on aerobic and hypoxic Chinese hamster cells_in vitro_. Br J Cancer 41: 569–573, 1980 Google Scholar
Tannock I, Guttman P: Response of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions. Br J Cancer 43: 245–248, 1981 Google Scholar
Fan D, Morgan LR, Schneider C, Blank H, Roy S, Wang YF, Fan S: Pharmacologic assessment of regimen chemosensitivity in soft agar assay: effect of oxygen on human tumors. J Cancer Res Clin Oncol 110: 209–215, 1985 Google Scholar
Richter A, Sanford KK, Evans VJ: Influence of oxygen and culture media on plating efficiency of some mammalian tissue cells. J Natl Cancer Inst 49: 1705–1712, 1972 Google Scholar
Pritsos CA, Sartorelli AS: Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics. Cancer Res 46: 3528–3532, 1986 Google Scholar
Oberley LW, Buettne GR: Role of superoxide dismutase in cancer: a review. Cancer Res 39: 1141–1149, 1979 Google Scholar
Bachur NR, Gordon SL, Gee MV, Kon H: NADPH-cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc Natl Acad Sci USA 76: 954–957, 1979 Google Scholar
Giavazzi R, Miller L, Hart IR: Metastatic behavior of an Adriamycin-resistant murine tumor. Cancer Res 43: 5081–5086, 1986 Google Scholar
Fidler IJ: Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Rev 5: 29–49, 1986 Google Scholar
Morikawa K, Walker SM, Jessup JM, Fidler IJ:In vivo selection of highly metastatic cells from surgical specimens of different human colon carcinomas implanted into nude mice. Cancer Res 48: 1943–1948, 1988 Google Scholar
Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM, Fidler IJ: The influence of organ environment on the growth, selection, and metastasis of human colon cancer cells in nude mice. Cancer Res 48: 6363–6871, 1988 Google Scholar
DeVore DP, Houchens DP, Ovejera AA, Dill Jr GS, Hutson TB: Collagenase inhibitors retarding invasion of a human tumor in nude mide. Exp Cell Biol 48: 367–373, 1980 Google Scholar
Nakajima M, Chop AM: Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors. Semin Cancer Biol 2: 115–127, 1991 Google Scholar
Nakajima M, Morikawa K, Fabra A, Bucana CD, Fidler IJ: Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst 82: 1890–1898, 1990 Google Scholar
Fabra A, Nakajima M, Bucana CD, Fidler IJ: Modulation of the invasive phenotype of human colon carcinoma cells by organ-specific fibroblasts of nude mice. Differentiation 52: 101–110, 1992 Google Scholar
August DA, Ottow RT, Sugarbaker PH: Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev 3: 303–324, 1984 Google Scholar
Kemeny N: Role of chemotherapy in the treatment of colorectal carcinoma. Semin Surg Oncol 3: 190–214, 1987 Google Scholar
Wilmanns C, Fan D, O'Brian CA, Radinsky R, Bucana CD, Tsan R, Fidler IJ: Modulation of doxorubicin sensitivity and level of P-glycoprotein expression in human colon carcinoma cells by ectopic and orthotopic environments in nude mice. Int J Oncol 3: 413–422, 1993 Google Scholar
Wolfman A, Wingrove IG, Blackshear PJ, Macara IG: Downregulation of protein kinase C and of an endogenous 80-kDa substrate in transformed fibroblasts. J Biol Chem 2672: 16546–16552, 1987 Google Scholar
Weyman CM, Taparowsky EJ, Woltson J, Ashendel CL: Partial downregulation of protein kinase C in C3H 10T1/2 mouse fibroblasts transfected with the human Ha-ras oncogene. Cancer Res 48: 6535–6541, 1988 Google Scholar
Guillem JG, O'Brian CA, Fitzer CJ, Forde KA, LoGerfo P, Treat M, Weinstein IB: Altered levels of protein kinase C and Ca2+-dependent protein kinases in human colon carcinomas. Cancer Res 47: 2036–2039, 1987 Google Scholar
Tsuruo T: Mechanisms of multidrug resistance and implication for therapy. Jpn J Cancer Res 79: 285–296, 1988 Google Scholar
Deuchars KL, Ling V: P-glycoprotein and multidrug resistance in cancer chemotherapy. Semin Oncol 16: 156–165, 1989 Google Scholar
Moscow JA, Cowan KH: Multidrug resistance. J Natl Cancer Inst 80: 14–20, 1988 Google Scholar
Gottesman MM, Pastan I: The multidrug transporter, a double-edged sword. J Biol Chem 263: 12163–12166, 1988 Google Scholar
Weinstein RS, Kuszak IR, Kluskens LF, Con JS: P-glycoprotein in pathology: the multidrug resistance gene family in humans. Hum Pathol 21: 34–48, 1990 Google Scholar
Melamed MR: Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 38: 1277–1287, 1990 Google Scholar
Charcasset JY, Alard C, Brousset P, Mazarolles C, Delsol G: Immunohistochemical detection of multidrug resistance-associated P-glycoprotein in tumor and stromal cells of human cancers.Br J Cancer 62: 177–182, 1990 Google Scholar
Thorgeirsson SS, Huber BE, Sorell S, Fojo A, Pastan I, Gottesman MM: Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver. Science 236: 1120–1122, 1987 Google Scholar
Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I: Expression of a multidrug resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84: 265–269, 1987 Google Scholar
Shimazu H, Tsuruo T, Sumizawa T, Akiyama S: Expression of the_mdr_1 gene in human gastric antral carcinomas. J Natl Cancer Inst 82: 1679–1683, 1990 Google Scholar
Shen DW, Fojo A, Chin IE, Ronninson B, Richert N, Pastan I, Gottesman MM: Human multidrug resistant cell lines: increased_mdr_1 expression can precede gene amplification. Science 232: 634–645, 1986 Google Scholar
Wilmanns C, Fan D, O'Brian CA, Bucana CD, Fidler IJ: Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil. Int J Cancer 52: 98–104, 1992 Google Scholar
Pastan I, Gottesman M: Multiple resistance in human cancer. New Engl J Med 316: 1388–1393, 1987 Google Scholar
Deffie AM, Alam T, Seneviratne C, Beenken SW, Batra IK, Shea TC, Henner WD, Goldenberg GJ: Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Cancer Res 48: 3595–3602, 1988 Google Scholar
Redmond SMS, Joncourt F, Buser K, Ziemiecki A, Altermatt H-J, Fey M, Margison G, Cerny T: Assessment of P-glycoprotein, glutathione-based detoxifying enzymes, and O6-alkylguanine-DNA alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumors. Cancer Res 51: 2092–2097, 1991 Google Scholar
Berger SH, Jenh C-H, Johnson LF, Berger FG: Thymidilate synthetase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells. Molec Pharmacol 28: 461–467, 1985 Google Scholar
Deuchars KL, Ling V: P-glycoprotein and multidrug resistance in cancer chemotherapy. Semin Oncol 16: 156–165, 1989 Google Scholar
Hutchinson DJ: Modes of acquiring resistance to antineoplastic agents. In: Berkada B, Karrer K, Mathe G (eds) Clinical Chemotherapy, vol 3. Thieme-Straton, New York, 1984, pp 368–383 Google Scholar
Fan D, Wilmanns C, O'Brian CA, Kuo MT, Teeter LD, Bucana CD, Ward NE, Fidler IJ: Orthotopic and ectopic modulation of P-glycoprotein and resistance to adriamycin of human colon carcinoma cells in nude mice. Proc Amer Assn Cancer Res 33: 468, 1992 Google Scholar
Sartorelli AC: Therapeutic attack of hypoxic cells of solid tumors: presidential address. Cancer Res 48: 775–778, 1988 Google Scholar
Tannock IF, Van Rotin D: Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 49: 4373–7384, 1989 Google Scholar
Collins JM: Pharmacokinetics of 5-fluorouracil infusions in the rat: comparison with man and other species. Cancer Chemother Pharmacol 14: 108–111, 1985 Google Scholar
Reddy BS, Watanabe K, Weisburger JH, Wynder EL: Promoting effect of bile acids in colon carcinogenesis in germfree and conventional F344 rats. Cancer Res 37: 3238–3242, 1977 Google Scholar
Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Grist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM, Pastan I: Expression of a multidrug resistance gene in human tumors. J Natl Cancer Inst 81: 116–124, 1989 Google Scholar
Weinstein RS, Jakate SM, Dominguez JM, Lebovitz MD, Koukoulis GK, Kuszak JR, Klusens LF, Grogen TM, Saclarides TJ, Roninson IB, Coon JS: Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 51: 2720–2726, 1991 Google Scholar
Fojo AT, Ueda K, Slamon DJ, Poplack D, Gottesman MM, Pastan I: Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84: 265–269, 1987 Google Scholar
Park JG, Kramer BS, Lai SL, Goldstein LJ, Gazdar AF: Chemosensitivity patterns and expression of human multidrug resistance-associated MDR1 gene by human gastric and colorectal carcinoma cell lines. J Natl Cancer Inst 82: 193–198, 1990 Google Scholar
Raghu G, Pierre-Jerome J, Dordal MS, Simonian P, Bauer KD, Winter JW: P-glycoprotein and alterations in the glutathione/glutathione-peroxidase cycle underlie doxorubicin resistance in HL-60-R, a subclone of the HL-60 human leukemia cell line. Int J Cancer 53: 804–811, 1993 Google Scholar
Mattern MVJ, Pomerenke EW: Time course of MDR gene amplification during_in vivo_ selection for doxorubicin-resistance and during reversal in murine leukemia L1210. Anticancer Res 11: 579–586, 1991 Google Scholar
Thorgeirsson SS, Huber BE, Sorrell S, Fojo SA, Pastan I, Gottesman MM: Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver. Science 236: 1120–1122, 1987 Google Scholar
Marino PA, Gottesman MM, Pastan I: Regulation of the multidrug resistance gene in regenerating rat liver. Cell Growth Differ 1: 57–62, 1990 Google Scholar
Michalopoulos GK: Liver regeneration: molecular mechanisms of growth control. FASEB J 4: 176–187, 1990 Google Scholar
Mead JE, Fausto N: Transforming growth factor α may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA 86: 1558–1562, 1989 Google Scholar
Gherardi E, Stoker M: Hepatocyte growth factor-scatter factor: Mitogen, motogen, and_met_. Cancer Cells 3: 227–232, 1991 Google Scholar
Cornwell MM, Smith DE: A signal transduction pathway for activation of the_mdr_1 promoter involves the protooncogene c-raf kinase. J Biol Chem 268: 15347–15350, 1993 Google Scholar
Baselga J, Norton L, Masui H, Pandiella A, Coplan K, Miller Jr WH, Mendelsohn J: Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst 85: 1327–1333, 1993 Google Scholar
Radinsky R: Paracrine growth regulation of human colon carcinoma organ-specific metastases. Cancer Metastasis Rev 12: 345–361, 1993 Google Scholar
Schuetz JD, Schuetz EG: Extracellular matrix regulation of multidrug resistance in primary monolayer cultures of adult rat hepatocytes. Cell Growth Differ 4: 31–40, 1993 Google Scholar
Chin K, Tanaka S, Darlington G, Pastan I, Gottesman MM: Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J Biol Chem 265: 221–226, 1990 Google Scholar
Fairchild CR, Ivy SP, Rushmore T, Lee G, Koo P, Goldsmith M, Myers C, Farber E, Cowan K: Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. Proc Natl Acad Sci USA 84: 7701–7705, 1987 Google Scholar
Chin K-V, Pastan I, Gottesman MM: Function and regulation of the human multidrug resistance gene. Adv Cancer Res 60: 1157–1180, 1993 Google Scholar
Chin K-V, Chauhan SS, Pastan I, Gottesman MM: Regulation of_mdr_1 RNA levels in response to cytotoxic drugs in rodent cells. Cell Growth Differen 1: 361–365, 1990 Google Scholar
Kohno K, Sato S, Takano H, Matsuo K, Kuesno M: The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem Biophys Res Commu 165: 1415–1421, 1989 Google Scholar